Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

7.97
Delayed Data
As of Apr 29
 -0.63 / -7.33%
Today’s Change
4.26
Today|||52-Week Range
16.25
+25.31%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close8.60
Today’s open8.49
Day’s range7.91 - 8.55
Volume46,721
Average volume (3 months)42,591
Market cap$574.3M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+17.38%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book1.22

Competitors

 Today’s
change
Today’s
% change
CFMSConforMIS Inc-0.80-6.07%
VASCVascular Solutions I...-0.16-0.46%
OFIXOrthofix Internation...+0.53+1.23%
IVCInvacare Corp+0.23+2.09%
Data as of 4:01pm ET, 04/29/2016

Financials

Next reporting dateJune 1, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts

Partner Offers

Search for Jobs